Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

Daniel Catovsky; S Richards; Estella Matutes; D Oscier; MJS Dyer; R. F. Bezares; A R Pettitt; T Hamblin; DW Milligan; JA Child; William Hamilton; CE Dearden; A J Smith; AG Bosanquet; Zadie Davis; V Brito-Babapulle; Monica Else; Rachel Wade; Peter Hillmen

doi:10.1016/s0140-6736(07)61125-8

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

Daniel Catovsky(Institute of Cancer Research), S Richards(MRC Clinical Trials Unit at UCL), Estella Matutes(Institute of Cancer Research), D Oscier(Royal Bournemouth Hospital), MJS Dyer(Leicester Royal Infirmary), R. F. Bezares(Hospital General de Agudos Dr. TEODORO ALVAREZ), A R Pettitt(University of Liverpool), T Hamblin(Royal Bournemouth Hospital), DW Milligan(Heartlands Hospital), JA Child(Leeds General Infirmary), William Hamilton(Good Hope Hospital), CE Dearden(Institute of Cancer Research), A J Smith(Southampton General Hospital), AG Bosanquet, Zadie Davis(Royal Bournemouth Hospital), V Brito-Babapulle(Institute of Cancer Research), Monica Else(Institute of Cancer Research), Rachel Wade(MRC Clinical Trials Unit at UCL), Peter Hillmen(Leeds General Infirmary)

The Lancet

July 1, 2007

10.1016/s0140-6736(07)61125-8

Cited by 679

Abstract

Related Papers

No related papers found

Powered by citation graph analysis